HEADER PROTEIN FIBRIL 28-JAN-14 4ONK
TITLE [LEU-5]-ENKEPHALIN MUTANT - YVVFL
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: [LEU-5]-ENKEPHALIN MUTANT - YVVFL;
COMPND 3 CHAIN: A, B;
COMPND 4 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 SYNTHETIC: YES;
SOURCE 3 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT;
SOURCE 4 ORGANISM_TAXID: 32630;
SOURCE 5 OTHER_DETAILS: SYNTHESIZED
KEYWDS AMYLOID-LIKE PROTOFIBRIL, PROTEIN FIBRIL
EXPDTA X-RAY DIFFRACTION
AUTHOR S.SANGWAN,D.EISENBERG,M.R.SAWAYA,T.D.DO,M.T.BOWERS,N.E.LAPOINTE,
AUTHOR 2 D.B.TEPLOW,S.C.FEINSTEIN
REVDAT 4 03-APR-24 4ONK 1 REMARK
REVDAT 3 28-FEB-24 4ONK 1 REMARK
REVDAT 2 06-AUG-14 4ONK 1 JRNL
REVDAT 1 02-JUL-14 4ONK 0
JRNL AUTH T.D.DO,N.E.LAPOINTE,S.SANGWAN,D.B.TEPLOW,S.C.FEINSTEIN,
JRNL AUTH 2 M.R.SAWAYA,D.S.EISENBERG,M.T.BOWERS
JRNL TITL FACTORS THAT DRIVE PEPTIDE ASSEMBLY FROM NATIVE TO AMYLOID
JRNL TITL 2 STRUCTURES: EXPERIMENTAL AND THEORETICAL ANALYSIS OF
JRNL TITL 3 [LEU-5]-ENKEPHALIN MUTANTS.
JRNL REF J.PHYS.CHEM.B V. 118 7247 2014
JRNL REFN ISSN 1089-5647
JRNL PMID 24915112
JRNL DOI 10.1021/JP502473S
REMARK 2
REMARK 2 RESOLUTION. 1.90 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : PHENIX DEV_1457
REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN
REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE,
REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER,
REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY,
REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON,
REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI,
REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT
REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART
REMARK 3
REMARK 3 REFINEMENT TARGET : LS_WUNIT_K1
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 9.28
REMARK 3 MIN(FOBS/SIGMA_FOBS) : 35.130
REMARK 3 COMPLETENESS FOR RANGE (%) : 93.9
REMARK 3 NUMBER OF REFLECTIONS : 522
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 R VALUE (WORKING + TEST SET) : 0.155
REMARK 3 R VALUE (WORKING SET) : 0.151
REMARK 3 FREE R VALUE : 0.199
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.000
REMARK 3 FREE R VALUE TEST SET COUNT : 47
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS).
REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE
REMARK 3 1 0.0000 - 1.9003 0.94 475 47 0.1513 0.1994
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL
REMARK 3 SOLVENT RADIUS : 1.11
REMARK 3 SHRINKAGE RADIUS : 0.90
REMARK 3 K_SOL : NULL
REMARK 3 B_SOL : NULL
REMARK 3
REMARK 3 ERROR ESTIMATES.
REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.290
REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 23.660
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 8.11
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 14.15
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : NULL
REMARK 3 B22 (A**2) : NULL
REMARK 3 B33 (A**2) : NULL
REMARK 3 B12 (A**2) : NULL
REMARK 3 B13 (A**2) : NULL
REMARK 3 B23 (A**2) : NULL
REMARK 3
REMARK 3 TWINNING INFORMATION.
REMARK 3 FRACTION: NULL
REMARK 3 OPERATOR: NULL
REMARK 3
REMARK 3 DEVIATIONS FROM IDEAL VALUES.
REMARK 3 RMSD COUNT
REMARK 3 BOND : 0.006 94
REMARK 3 ANGLE : 0.842 128
REMARK 3 CHIRALITY : 0.039 16
REMARK 3 PLANARITY : 0.006 14
REMARK 3 DIHEDRAL : 10.952 28
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 NCS DETAILS
REMARK 3 NUMBER OF NCS GROUPS : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 4ONK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-FEB-14.
REMARK 100 THE DEPOSITION ID IS D_1000084717.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 08-AUG-13
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : NULL
REMARK 200 NUMBER OF CRYSTALS USED : 3
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : APS
REMARK 200 BEAMLINE : 24-ID-E
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.9791
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO
REMARK 200 DATA SCALING SOFTWARE : SCALEPACK
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 537
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900
REMARK 200 RESOLUTION RANGE LOW (A) : 100.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 96.9
REMARK 200 DATA REDUNDANCY : 3.800
REMARK 200 R MERGE (I) : 0.15100
REMARK 200 R SYM (I) : NULL
REMARK 200 FOR THE DATA SET : 10.7000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.97
REMARK 200 COMPLETENESS FOR SHELL (%) : 90.9
REMARK 200 DATA REDUNDANCY IN SHELL : 3.40
REMARK 200 R MERGE FOR SHELL (I) : 0.15300
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER 2.5.2
REMARK 200 STARTING MODEL: IDEAL BETA STRAND WITH SEQUENCE AVVAA
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): NULL
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): NULL
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: RESERVOIR CONTAINED 25% PEG 3350, 0.2M
REMARK 280 POTASSIUM THIOCYANATE, VAPOR DIFFUSION, HANGING DROP,
REMARK 280 TEMPERATURE 298K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 300 REMARK: THE BIOLOGICAL UNIT IS A PAIR OF BETA SHEETS. ONE SHEET IS
REMARK 300 CONSTRUCTED FROM CHAINS A AND B WITH UNIT CELL TRANSLATIONS ALONG
REMARK 300 THE A DIRECTION (I.E. X+1,Y,Z; X+2,Y,Z; X+3,Y,Z, ETC.). THE SECOND
REMARK 300 SHEET IS CONSTRUCTED FROM X,Y+1,Z; X+1,Y+1,Z; X+2,Y+1,Z; ETC.).
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DODECAMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 9.61300
REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000
REMARK 350 BIOMT1 3 1.000000 0.000000 0.000000 19.22600
REMARK 350 BIOMT2 3 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000
REMARK 350 BIOMT1 4 1.000000 0.000000 0.000000 -4.34157
REMARK 350 BIOMT2 4 0.000000 1.000000 0.000000 13.12771
REMARK 350 BIOMT3 4 0.000000 0.000000 1.000000 0.00000
REMARK 350 BIOMT1 5 1.000000 0.000000 0.000000 5.27143
REMARK 350 BIOMT2 5 0.000000 1.000000 0.000000 13.12771
REMARK 350 BIOMT3 5 0.000000 0.000000 1.000000 0.00000
REMARK 350 BIOMT1 6 1.000000 0.000000 0.000000 14.88443
REMARK 350 BIOMT2 6 0.000000 1.000000 0.000000 13.12771
REMARK 350 BIOMT3 6 0.000000 0.000000 1.000000 0.00000
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 4OLR RELATED DB: PDB
REMARK 900 LEU-5 ENKEPHALIN MUTANT
DBREF 4ONK A 1 5 PDB 4ONK 4ONK 1 5
DBREF 4ONK B 1 5 PDB 4ONK 4ONK 1 5
SEQRES 1 A 5 TYR VAL VAL PHE LEU
SEQRES 1 B 5 TYR VAL VAL PHE LEU
FORMUL 3 HOH *3(H2 O)
SHEET 1 A 2 VAL A 2 PHE A 4 0
SHEET 2 A 2 VAL B 2 PHE B 4 -1 O PHE B 4 N VAL A 2
CRYST1 9.613 13.827 14.835 90.61 103.12 108.30 P 1 2
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.104026 0.034397 0.027390 0.00000
SCALE2 0.000000 0.076173 0.006768 0.00000
SCALE3 0.000000 0.000000 0.069486 0.00000
ATOM 1 N TYR A 1 1.565 0.138 -1.868 1.00 15.08 N
ATOM 2 CA TYR A 1 1.230 0.193 -0.445 1.00 15.38 C
ATOM 3 C TYR A 1 1.824 1.417 0.229 1.00 14.41 C
ATOM 4 O TYR A 1 3.029 1.629 0.160 1.00 11.24 O
ATOM 5 CB TYR A 1 1.726 -1.060 0.266 1.00 13.95 C
ATOM 6 CG TYR A 1 1.461 -1.082 1.756 1.00 13.59 C
ATOM 7 CD1 TYR A 1 0.226 -1.478 2.249 1.00 16.41 C
ATOM 8 CD2 TYR A 1 2.452 -0.732 2.670 1.00 13.76 C
ATOM 9 CE1 TYR A 1 -0.027 -1.515 3.603 1.00 16.02 C
ATOM 10 CE2 TYR A 1 2.208 -0.758 4.035 1.00 15.36 C
ATOM 11 CZ TYR A 1 0.966 -1.156 4.492 1.00 19.20 C
ATOM 12 OH TYR A 1 0.702 -1.200 5.840 1.00 21.18 O
ATOM 13 N VAL A 2 0.987 2.225 0.879 1.00 10.79 N
ATOM 14 CA VAL A 2 1.489 3.393 1.604 1.00 12.56 C
ATOM 15 C VAL A 2 0.795 3.578 2.944 1.00 12.02 C
ATOM 16 O VAL A 2 -0.429 3.462 3.043 1.00 10.79 O
ATOM 17 CB VAL A 2 1.312 4.695 0.799 1.00 14.29 C
ATOM 18 CG1 VAL A 2 1.815 5.888 1.598 1.00 12.86 C
ATOM 19 CG2 VAL A 2 2.018 4.619 -0.544 1.00 16.40 C
ATOM 20 N VAL A 3 1.578 3.862 3.978 1.00 9.30 N
ATOM 21 CA VAL A 3 1.013 4.295 5.249 1.00 11.13 C
ATOM 22 C VAL A 3 1.669 5.604 5.670 1.00 11.64 C
ATOM 23 O VAL A 3 2.895 5.717 5.662 1.00 10.32 O
ATOM 24 CB VAL A 3 1.195 3.225 6.352 1.00 8.88 C
ATOM 25 CG1 VAL A 3 0.769 3.762 7.704 1.00 11.59 C
ATOM 26 CG2 VAL A 3 0.399 1.989 6.013 1.00 11.53 C
ATOM 27 N PHE A 4 0.856 6.604 6.002 1.00 9.31 N
ATOM 28 CA PHE A 4 1.381 7.825 6.601 1.00 11.61 C
ATOM 29 C PHE A 4 0.805 8.011 7.998 1.00 13.96 C
ATOM 30 O PHE A 4 -0.411 7.936 8.190 1.00 11.95 O
ATOM 31 CB PHE A 4 1.073 9.057 5.745 1.00 11.36 C
ATOM 32 CG PHE A 4 1.344 10.352 6.454 1.00 13.26 C
ATOM 33 CD1 PHE A 4 2.640 10.834 6.565 1.00 12.66 C
ATOM 34 CD2 PHE A 4 0.313 11.070 7.044 1.00 14.79 C
ATOM 35 CE1 PHE A 4 2.907 12.013 7.243 1.00 14.35 C
ATOM 36 CE2 PHE A 4 0.569 12.251 7.725 1.00 15.02 C
ATOM 37 CZ PHE A 4 1.872 12.725 7.825 1.00 16.54 C
ATOM 38 N LEU A 5 1.676 8.257 8.970 1.00 11.16 N
ATOM 39 CA LEU A 5 1.224 8.495 10.336 1.00 13.03 C
ATOM 40 C LEU A 5 1.867 9.743 10.943 1.00 16.38 C
ATOM 41 O LEU A 5 3.085 9.920 10.904 1.00 13.52 O
ATOM 42 CB LEU A 5 1.520 7.283 11.214 1.00 15.47 C
ATOM 43 CG LEU A 5 0.895 7.373 12.605 1.00 18.47 C
ATOM 44 CD1 LEU A 5 -0.552 7.755 12.467 1.00 20.64 C
ATOM 45 CD2 LEU A 5 0.986 6.058 13.319 1.00 22.76 C
ATOM 46 OXT LEU A 5 1.182 10.603 11.508 1.00 15.56 O
TER 47 LEU A 5
ATOM 48 N TYR B 1 -3.954 10.206 9.758 1.00 12.93 N
ATOM 49 CA TYR B 1 -3.486 8.872 9.383 1.00 14.65 C
ATOM 50 C TYR B 1 -4.150 8.387 8.107 1.00 13.84 C
ATOM 51 O TYR B 1 -5.365 8.453 7.983 1.00 13.58 O
ATOM 52 CB TYR B 1 -3.764 7.875 10.507 1.00 11.56 C
ATOM 53 CG TYR B 1 -3.535 6.427 10.134 1.00 14.66 C
ATOM 54 CD1 TYR B 1 -2.303 5.831 10.340 1.00 13.98 C
ATOM 55 CD2 TYR B 1 -4.560 5.645 9.599 1.00 14.45 C
ATOM 56 CE1 TYR B 1 -2.085 4.502 10.025 1.00 17.66 C
ATOM 57 CE2 TYR B 1 -4.349 4.309 9.272 1.00 17.46 C
ATOM 58 CZ TYR B 1 -3.103 3.744 9.490 1.00 17.32 C
ATOM 59 OH TYR B 1 -2.866 2.423 9.178 1.00 18.48 O
ATOM 60 N VAL B 2 -3.365 7.874 7.167 1.00 11.39 N
ATOM 61 CA VAL B 2 -3.955 7.245 6.002 1.00 10.32 C
ATOM 62 C VAL B 2 -3.200 5.980 5.643 1.00 11.60 C
ATOM 63 O VAL B 2 -1.976 5.900 5.779 1.00 8.29 O
ATOM 64 CB VAL B 2 -3.992 8.195 4.776 1.00 12.92 C
ATOM 65 CG1 VAL B 2 -2.587 8.472 4.254 1.00 12.80 C
ATOM 66 CG2 VAL B 2 -4.866 7.608 3.665 1.00 11.13 C
ATOM 67 N VAL B 3 -3.949 4.978 5.207 1.00 10.85 N
ATOM 68 CA VAL B 3 -3.351 3.805 4.600 1.00 11.67 C
ATOM 69 C VAL B 3 -4.038 3.567 3.267 1.00 11.22 C
ATOM 70 O VAL B 3 -5.263 3.625 3.167 1.00 9.02 O
ATOM 71 CB VAL B 3 -3.467 2.555 5.505 1.00 11.70 C
ATOM 72 CG1 VAL B 3 -4.896 2.366 5.994 1.00 11.87 C
ATOM 73 CG2 VAL B 3 -2.975 1.315 4.770 1.00 12.95 C
ATOM 74 N PHE B 4 -3.255 3.346 2.223 1.00 12.24 N
ATOM 75 CA PHE B 4 -3.870 2.925 0.982 1.00 12.78 C
ATOM 76 C PHE B 4 -3.057 1.864 0.274 1.00 14.83 C
ATOM 77 O PHE B 4 -1.828 1.850 0.334 1.00 12.15 O
ATOM 78 CB PHE B 4 -4.133 4.116 0.061 1.00 15.64 C
ATOM 79 CG PHE B 4 -2.951 5.007 -0.188 1.00 16.11 C
ATOM 80 CD1 PHE B 4 -2.647 6.045 0.685 1.00 20.56 C
ATOM 81 CD2 PHE B 4 -2.201 4.873 -1.345 1.00 17.43 C
ATOM 82 CE1 PHE B 4 -1.579 6.908 0.433 1.00 18.84 C
ATOM 83 CE2 PHE B 4 -1.138 5.728 -1.604 1.00 18.61 C
ATOM 84 CZ PHE B 4 -0.833 6.752 -0.715 1.00 18.54 C
ATOM 85 N LEU B 5 -3.765 0.954 -0.380 1.00 14.34 N
ATOM 86 CA LEU B 5 -3.119 -0.197 -0.977 1.00 12.93 C
ATOM 87 C LEU B 5 -3.948 -0.759 -2.118 1.00 14.20 C
ATOM 88 O LEU B 5 -5.173 -0.691 -2.085 1.00 13.42 O
ATOM 89 CB LEU B 5 -2.879 -1.263 0.092 1.00 15.25 C
ATOM 90 CG LEU B 5 -4.081 -1.683 0.947 1.00 15.53 C
ATOM 91 CD1 LEU B 5 -4.844 -2.842 0.324 1.00 16.23 C
ATOM 92 CD2 LEU B 5 -3.624 -2.051 2.342 1.00 15.90 C
ATOM 93 OXT LEU B 5 -3.418 -1.303 -3.086 1.00 14.69 O
TER 94 LEU B 5
HETATM 95 O HOH A 101 -2.482 12.660 8.666 1.00 18.12 O
HETATM 96 O HOH B 101 0.109 2.087 -2.898 1.00 22.25 O
HETATM 97 O HOH B 102 -3.592 2.493 -4.306 1.00 13.75 O
MASTER 199 0 0 0 2 0 0 6 95 2 0 2
END